Impact of neuroleptic medications on continuous performance test measures in schizophrenia

被引:29
作者
Epstein, JI [1 ]
Keefe, RSE [1 ]
Roitman, SL [1 ]
Harvey, PD [1 ]
Mohs, RC [1 ]
机构
[1] VET ADM MED CTR, PSYCHIAT SERV 116A, MT SINAI MED CTR, DEPT PSYCHIAT, BRONX, NY 10468 USA
关键词
attention; continuous performance test; medication; neuroleptic; schizophrenia;
D O I
10.1016/0006-3223(95)00588-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
[No abstract available]
引用
收藏
页码:902 / 905
页数:4
相关论文
共 15 条
[11]   ATTENTIONAL VULNERABILITY INDICATORS, THOUGHT-DISORDER, AND NEGATIVE SYMPTOMS [J].
NUECHTERLEIN, KH ;
EDELL, WS ;
NORRIS, M ;
DAWSON, ME .
SCHIZOPHRENIA BULLETIN, 1986, 12 (03) :408-426
[12]   PSYCHOMETRIC SCHIZOTYPY AND SUSTAINED ATTENTION IN YOUNG MALES [J].
OBIOLS, JE ;
GARCIADOMINGO, M ;
DETRINCHERIA, I ;
DOMENECH, E .
PERSONALITY AND INDIVIDUAL DIFFERENCES, 1993, 14 (02) :381-384
[13]  
OVERALL K, 1968, PSYCHOL REP, V10, P799
[14]   MEDICATION MAY BE REQUIRED FOR THE DEVELOPMENT OF AUTOMATIC INFORMATION-PROCESSING IN SCHIZOPHRENIA [J].
SERPER, MR ;
BERGMAN, RL ;
HARVEY, PD .
PSYCHIATRY RESEARCH, 1990, 32 (03) :281-288
[15]  
WOHLBERG GW, 1973, ARCH GEN PSYCHIAT, V28, P533